HIGH-VOLUME · SEX-BALANCED
mirabegron Side Effects
mirabegron (also sold as Myrbetriq) is HIGH-VOLUME in this FAERS book #168 of 524 by FAERS report count. Signature opener: SEX-BALANCED - 67% of sex-coded reports are female (23,006 F / 11,471 M).
Data updated 2026-05-15
- 36,931
- FAERS reports
FAERS voluntary reports, 2010 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
mirabegron reporting skew - 67% of sex-coded reports are female (23,006 F / 11,471 M). Volume band HIGH-VOLUME #168 of 524 by FAERS report count; caseload CASELOAD.
High-report extract for mirabegron (Myrbetriq): 36,931 FAERS rows (2010-2025). Top named reactions: FATIGUE, HEADACHE, DIZZINESS. Outcome stamps DEATH-HEAVY · HOSP-MID · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2010–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
FATIGUE leads 2,215 of 36,931 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (8,928 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (2,913 reports, 7.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 972 |
| MATERNAL EXPOSURE DURING PREGNANCY | 651 |
| CONFUSIONAL STATE | 647 |
| PAIN | 639 |
| INFUSION RELATED REACTION | 624 |
| PEMPHIGUS | 615 |
| C-REACTIVE PROTEIN INCREASED | 609 |
| SYNOVITIS | 601 |
| PSORIATIC ARTHROPATHY | 597 |
| TYPE 2 DIABETES MELLITUS | 596 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 595 |
| SYSTEMIC LUPUS ERYTHEMATOSUS | 590 |
| GASTROOESOPHAGEAL REFLUX DISEASE | 585 |
| PERICARDITIS | 583 |
| FOLLICULITIS | 573 |
| RASH | 573 |
| RHEUMATOID ARTHRITIS | 573 |
| GLOSSODYNIA | 567 |
Reactions in Hospitalization Reports
Hospitalization mid-share (7,208, 19.5%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| FALL | 1,087 |
| PAIN | 868 |
| FATIGUE | 835 |
| ASTHENIA | 830 |
| PNEUMONIA | 827 |
| CONFUSIONAL STATE | 823 |
| DIARRHOEA | 758 |
| NAUSEA | 734 |
| DYSPNOEA | 709 |
| RASH | 701 |
| HYPERTENSION | 689 |
| DIZZINESS | 685 |
| ARTHRALGIA | 661 |
| VOMITING | 661 |
| HEADACHE | 635 |
| INFUSION RELATED REACTION | 622 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 604 |
| C-REACTIVE PROTEIN INCREASED | 603 |
How to read mirabegron FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-MID)
FAERS holds 36,931 voluntary reports linked to mirabegron (Myrbetriq), 2010-2025. Death is listed on 2,913 (7.9%). Hospitalization appears on 7,208 (19.5%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; SEX-BALANCED is the page opener, not a per-patient risk.
Read with mirabegron
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 36,917 FAERS cases (Δ 14 lighter vs mirabegron); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 36,885 FAERS cases (Δ 46 lighter vs mirabegron); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 37,033 FAERS cases (Δ 102 heavier vs mirabegron); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 37,361 FAERS cases (Δ 430 heavier vs mirabegron); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 54.2 pp vs mirabegron's DEATH-HEAVY): CASELOAD · HOSP-MID.
mirabegron stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.